Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Circadian Resetting Effects of Escitalopram and Testing for Correlations Between Circadian Resetting and Antidepressant Effects

NCT01214044 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT01214044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01214044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Circadian Resetting Effects of Escitalopram and Testing for Correlations Between Circadian Resetting and Antidepressant Effects
Lead sponsor
Oregon Health and Science University
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2008
Completion date
December 31, 2011
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression